Concepedia

Publication | Open Access

Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial

579

Citations

36

References

2009

Year

Abstract

NCT00274703.

References

YearCitations

Page 1